Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients
Open Access
- 13 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1127352
Abstract
Introduction: Severe COVID-19 originates a myriad of alterations in the immune system during active disease, especially in the T and NK cell compartments, but several studies in the last year have unveiled some alterations that persist in convalescence. Although most of the studies follow the participants for a short recovery time, studies following patients up to three or six months still find alterations. We aimed at evaluating changes in the NK, T and B cell compartments after severe COVID-19 in participants with a median recovery time of eleven months.Methods: Eighteen convalescent of severe COVID-19 (CSC), 14 convalescent of mild COVID-19 (CMC) and nine controls were recruited. NKG2A, NKG2C, NKG2D and the activating receptor NKp44 were evaluated in NKbright, NKdim and NKT subpopulations. In addition, CD3 and CD19 were measured and a basic biochemistry with IL-6 levels was obtained.Results: CSC participants showed lower NKbright/NKdim ratio, higher NKp44 expression in NKbright subpopulations, higher levels of serum IL-6, lower levels of NKG2A+ T lymphocytes and a trend to a lower expression of CD19 in B lymphocytes compared to controls. CMC participants showed no significant alterations in the immune system compared to controls.Conclusions: These results are concordant with previous studies, which find alterations in CSC weeks or months after resolution of the symptoms, and point to the possibility of these alterations lasting one year or more after COVID-19 resolution.Keywords
This publication has 34 references indexed in Scilit:
- CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple SclerosisJournal of Clinical Medicine, 2020
- NKG2A and COVID-19: another brick in the wallCellular & Molecular Immunology, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019Journal of Clinical Investigation, 2020
- NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in HumansFrontiers in Immunology, 2019
- Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypesNature Communications, 2015
- Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8 + T-cell immunityProceedings of the National Academy of Sciences, 2011
- Natural killer cells act as rheostats modulating antiviral T cellsNature, 2011
- Expansion of a unique CD57+NKG2Chinatural killer cell subset during acute human cytomegalovirus infectionProceedings of the National Academy of Sciences, 2011
- Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirusJournal of Experimental Medicine, 2010
- IL-12-Dependent Inducible Expression of the CD94/NKG2A Inhibitory Receptor Regulates CD94/NKG2C+ NK Cell FunctionThe Journal of Immunology, 2009